ALIM AL-BARI, Abdul, ITO, Yuko, THOMES, Paul G., MENON, Manoj B., GARCÍA-MACIA, Marina, FADEL, Raouf, STADLIN, Alfreda, PEAKE, Nicholas, FARIS, MoezAlIslam Ezzat, EID, Nabil and KLIONSKY, Daniel J. (2023). Emerging mechanistic insights of selective autophagy in hepatic diseases. Frontiers in Pharmacology, 14.
|
PDF
fphar-14-1149809.pdf - Published Version Creative Commons Attribution. Download (4MB) | Preview |
|
|
PDF
DataSheet1.pdf - Supplemental Material Creative Commons Attribution. Download (792kB) | Preview |
Abstract
Macroautophagy (hereafter referred to as autophagy), a highly conserved metabolic process, regulates cellular homeostasis by degrading dysfunctional cytosolic constituents and invading pathogens via the lysosomal system. In addition, autophagy selectively recycles specific organelles such as damaged mitochondria (via mitophagy), and lipid droplets (LDs; via lipophagy) or eliminates specialized intracellular pathogenic microorganisms such as hepatitis B virus (HBV) and coronaviruses (via virophagy). Selective autophagy, particularly mitophagy, plays a key role in the preservation of healthy liver physiology, and its dysfunction is connected to the pathogenesis of a wide variety of liver diseases. For example, lipophagy has emerged as a defensive mechanism against chronic liver diseases. There is a prominent role for mitophagy and lipophagy in hepatic pathologies including non-alcoholic fatty liver disease (NAFLD), hepatocellular carcinoma (HCC), and drug-induced liver injury. Moreover, these selective autophagy pathways including virophagy are being investigated in the context of viral hepatitis and, more recently, the coronavirus disease 2019 (COVID-19)-associated hepatic pathologies. The interplay between diverse types of selective autophagy and its impact on liver diseases is briefly addressed. Thus, modulating selective autophagy (e.g., mitophagy) would seem to be effective in improving liver diseases. Considering the prominence of selective autophagy in liver physiology, this review summarizes the current understanding of the molecular mechanisms and functions of selective autophagy (mainly mitophagy and lipophagy) in liver physiology and pathophysiology. This may help in finding therapeutic interventions targeting hepatic diseases via manipulation of selective autophagy.
Item Type: | Article |
---|---|
Additional Information: | ** From Frontiers via Jisc Publications Router ** Licence for this article: http://creativecommons.org/licenses/by/4.0/ ** Peer reviewed: TRUE **Journal IDs: eissn 1663-9812 **Article IDs: publisher-id: 1149809 **History: published_online 16-03-2023; accepted 23-02-2023; submitted 23-01-2023; collection 2023 |
Uncontrolled Keywords: | Pharmacology, autophagy, lipophagy, liver disease, mitophagy, TFEB, virophagy |
Identification Number: | https://doi.org/10.3389/fphar.2023.1149809 |
SWORD Depositor: | Colin Knott |
Depositing User: | Colin Knott |
Date Deposited: | 03 Apr 2023 10:13 |
Last Modified: | 03 Apr 2023 10:13 |
URI: | https://shura.shu.ac.uk/id/eprint/31708 |
Actions (login required)
![]() |
View Item |
Downloads
Downloads per month over past year